HEADER IMMUNE SYSTEM 21-MAY-01 1J8H TITLE CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, TITLE 2 INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR4 CAVEAT 1J8H NAG B 521 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 5 SYNONYM: HLA-DR1, DRA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR-4 BETA CHAIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 11 SYNONYM: HLA-DR4, DRB1*0401; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: HEMAGGLUTININ HA1 PEPTIDE CHAIN; COMPND 15 CHAIN: C; COMPND 16 FRAGMENT: ANTIGEN PEPTIDE; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 4; COMPND 19 MOLECULE: T-CELL RECEPTOR ALPHA CHAIN; COMPND 20 CHAIN: D; COMPND 21 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 22 SYNONYM: TCR HA1.7 ALPHA CHAIN; COMPND 23 ENGINEERED: YES; COMPND 24 MOL_ID: 5; COMPND 25 MOLECULE: T-CELL RECEPTOR BETA CHAIN; COMPND 26 CHAIN: E; COMPND 27 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 28 SYNONYM: TCR HA1.7 BETA CHAIN; COMPND 29 ENGINEERED: YES; COMPND 30 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SCHNEIDER; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 14 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: SCHNEIDER; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: INFLUENZAVIRUS A; SOURCE 19 ORGANISM_TAXID: 197911; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 21 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 22 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 23 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 24 EXPRESSION_SYSTEM_PLASMID: PLM1; SOURCE 25 MOL_ID: 4; SOURCE 26 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 27 ORGANISM_COMMON: HUMAN; SOURCE 28 ORGANISM_TAXID: 9606; SOURCE 29 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 30 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 31 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 32 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 33 EXPRESSION_SYSTEM_PLASMID: PLM1; SOURCE 34 MOL_ID: 5; SOURCE 35 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 36 ORGANISM_COMMON: HUMAN; SOURCE 37 ORGANISM_TAXID: 9606; SOURCE 38 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 39 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 40 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 41 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 42 EXPRESSION_SYSTEM_PLASMID: PLM1 KEYWDS PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.HENNECKE,D.C.WILEY REVDAT 7 16-OCT-24 1J8H 1 REMARK REVDAT 6 16-AUG-23 1J8H 1 REMARK REVDAT 5 27-OCT-21 1J8H 1 SEQADV HETSYN REVDAT 4 29-JUL-20 1J8H 1 CAVEAT COMPND REMARK SEQADV REVDAT 4 2 1 HETNAM LINK SITE ATOM REVDAT 3 13-JUL-11 1J8H 1 VERSN REVDAT 2 24-FEB-09 1J8H 1 VERSN REVDAT 1 13-MAR-02 1J8H 0 JRNL AUTH J.HENNECKE,D.C.WILEY JRNL TITL STRUCTURE OF A COMPLEX OF THE HUMAN ALPHA/BETA T CELL JRNL TITL 2 RECEPTOR (TCR) HA1.7, INFLUENZA HEMAGGLUTININ PEPTIDE, AND JRNL TITL 3 MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II MOLECULE, HLA-DR4 JRNL TITL 4 (DRA*0101 AND DRB1*0401): INSIGHT INTO TCR CROSS-RESTRICTION JRNL TITL 5 AND ALLOREACTIVITY. JRNL REF J.EXP.MED. V. 195 571 2002 JRNL REFN ISSN 0022-1007 JRNL PMID 11877480 JRNL DOI 10.1084/JEM.20011194 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1769191.790 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 46185 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2280 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.49 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4354 REMARK 3 BIN R VALUE (WORKING SET) : 0.3200 REMARK 3 BIN FREE R VALUE : 0.3580 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 222 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6547 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 305 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.18000 REMARK 3 B22 (A**2) : 1.05000 REMARK 3 B33 (A**2) : -7.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.97000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 20.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.520 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.510 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.340 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.490 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 38.44 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1J8H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAY-01. REMARK 100 THE DEPOSITION ID IS D_1000013491. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-AUG-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46185 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 19.810 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.33000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1FYT.PDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 13% PEG 8000, 1 M NACL, 100 MM HEPES, REMARK 280 PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 71.87650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.65850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 71.87650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.65850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -58.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 1 REMARK 465 GLY B 1 REMARK 465 ASP B 2 REMARK 465 LYS B 105 REMARK 465 THR B 106 REMARK 465 GLN B 107 REMARK 465 PRO B 108 REMARK 465 LEU B 109 REMARK 465 GLN B 110 REMARK 465 HIS B 111 REMARK 465 HIS B 112 REMARK 465 ARG B 191 REMARK 465 SER B 192 REMARK 465 ASP D 130 REMARK 465 SER D 131 REMARK 465 LYS D 132 REMARK 465 PHE D 204 REMARK 465 PRO D 205 REMARK 465 SER D 206 REMARK 465 PRO D 207 REMARK 465 GLU D 208 REMARK 465 SER D 209 REMARK 465 SER D 210 REMARK 465 CYS D 211 REMARK 465 ASP D 212 REMARK 465 VAL D 213 REMARK 465 LYS D 214 REMARK 465 ASP E 247 REMARK 465 CYS E 248 REMARK 465 GLY E 249 REMARK 465 PHE E 250 REMARK 465 THR E 251 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN D 152 CG CD OE1 NE2 REMARK 470 LYS D 154 CG CD CE NZ REMARK 470 ASP D 157 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP E 51 O HOH E 295 2.09 REMARK 500 OD2 ASP A 110 O HOH A 577 2.15 REMARK 500 O HOH A 533 O HOH E 295 2.17 REMARK 500 O HOH E 297 O HOH E 346 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 4 -52.82 -126.69 REMARK 500 HIS B 33 -109.07 71.48 REMARK 500 TYR B 78 -73.32 -128.21 REMARK 500 THR B 90 -71.99 -123.85 REMARK 500 PRO B 124 -168.87 -63.40 REMARK 500 SER D 51 0.82 83.09 REMARK 500 PHE D 73 61.33 -151.67 REMARK 500 ALA D 86 -170.88 -172.98 REMARK 500 LYS D 103 127.67 -34.31 REMARK 500 PRO D 121 155.08 -48.66 REMARK 500 ASP D 122 47.14 -168.66 REMARK 500 PRO D 123 135.65 -30.63 REMARK 500 ALA D 124 144.91 -170.11 REMARK 500 SER D 146 37.41 -71.79 REMARK 500 PHE D 193 37.22 -92.37 REMARK 500 ASN D 194 20.17 -52.86 REMARK 500 SER D 196 79.64 55.42 REMARK 500 SER E 7 -70.15 -41.84 REMARK 500 SER E 88 -176.71 -176.29 REMARK 500 PRO E 100 20.04 -61.44 REMARK 500 PHE E 154 137.26 -171.09 REMARK 500 PRO E 155 -162.74 -75.04 REMARK 500 HIS E 157 68.29 -113.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DLH RELATED DB: PDB REMARK 900 1DLH CONTAINS THE COMPLEX OF HLA-DR1 WITH THE HA306-318 ANTIGEN REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1FYT RELATED DB: PDB REMARK 900 1FYT CONTAINS THE COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, REMARK 900 INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 REMARK 900 RELATED ID: 2SEB RELATED DB: PDB REMARK 900 2SEB CONTAINS THE COMPLEX OF HLA-DR4 WITH A COLLAGEN ANTIGEN PEPTIDE DBREF 1J8H A 1 181 UNP P01903 HA2R_HUMAN 26 206 DBREF 1J8H B 1 192 UNP P13760 HB2H_HUMAN 30 221 DBREF 1J8H C 306 318 UNP P03437 HEMA_IAAIC 322 334 DBREF 1J8H D 1 214 PIR RWHUAC RWHUAC 21 232 DBREF 1J8H E 2 251 PIR S18894 S18894 21 266 SEQADV 1J8H VAL B 180 UNP P13760 LEU 209 CONFLICT SEQADV 1J8H SER E 192 PIR S18894 CYS 207 ENGINEERED MUTATION SEQRES 1 A 181 ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR SEQRES 2 A 181 LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE SEQRES 3 A 181 ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS SEQRES 4 A 181 GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SEQRES 5 A 181 SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL SEQRES 6 A 181 ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN SEQRES 7 A 181 TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL SEQRES 8 A 181 LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL SEQRES 9 A 181 LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL SEQRES 10 A 181 ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR SEQRES 11 A 181 GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS SEQRES 12 A 181 LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER SEQRES 13 A 181 THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY SEQRES 14 A 181 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP SEQRES 1 B 192 GLY ASP THR ARG PRO ARG PHE LEU GLU GLN VAL LYS HIS SEQRES 2 B 192 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE SEQRES 3 B 192 LEU ASP ARG TYR PHE TYR HIS GLN GLU GLU TYR VAL ARG SEQRES 4 B 192 PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU SEQRES 5 B 192 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 B 192 ASP LEU LEU GLU GLN LYS ARG ALA ALA VAL ASP THR TYR SEQRES 7 B 192 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 B 192 GLN ARG ARG VAL TYR PRO GLU VAL THR VAL TYR PRO ALA SEQRES 9 B 192 LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 B 192 SER VAL ASN GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 B 192 TRP PHE ARG ASN GLY GLN GLU GLU LYS THR GLY VAL VAL SEQRES 12 B 192 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 B 192 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 B 192 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 B 192 PRO LEU THR VAL GLU TRP ARG ALA ARG SER SEQRES 1 C 13 PRO LYS TYR VAL LYS GLN ASN THR LEU LYS LEU ALA THR SEQRES 1 D 212 GLN SER VAL THR GLN LEU GLY SER HIS VAL SER VAL SER SEQRES 2 D 212 GLU GLY ALA LEU VAL LEU LEU ARG CYS ASN TYR SER SER SEQRES 3 D 212 SER VAL PRO PRO TYR LEU PHE TRP TYR VAL GLN TYR PRO SEQRES 4 D 212 ASN GLN GLY LEU GLN LEU LEU LEU LYS TYR THR SER ALA SEQRES 5 D 212 ALA THR LEU VAL LYS GLY ILE ASN GLY PHE GLU ALA GLU SEQRES 6 D 212 PHE LYS LYS SER GLU THR SER PHE HIS LEU THR LYS PRO SEQRES 7 D 212 SER ALA HIS MET SER ASP ALA ALA GLU TYR PHE CYS ALA SEQRES 8 D 212 VAL SER GLU SER PRO PHE GLY ASN GLU LYS LEU THR PHE SEQRES 9 D 212 GLY THR GLY THR ARG LEU THR ILE ILE PRO ASN ILE GLN SEQRES 10 D 212 ASN PRO ASP PRO ALA VAL TYR GLN LEU ARG ASP SER LYS SEQRES 11 D 212 SER SER ASP LYS SER VAL CYS LEU PHE THR ASP PHE ASP SEQRES 12 D 212 SER GLN THR ASN VAL SER GLN SER LYS ASP SER ASP VAL SEQRES 13 D 212 TYR ILE THR ASP LYS THR VAL LEU ASP MET ARG SER MET SEQRES 14 D 212 ASP PHE LYS SER ASN SER ALA VAL ALA TRP SER ASN LYS SEQRES 15 D 212 SER ASP PHE ALA CYS ALA ASN ALA PHE ASN ASN SER ILE SEQRES 16 D 212 ILE PRO GLU ASP THR PHE PHE PRO SER PRO GLU SER SER SEQRES 17 D 212 CYS ASP VAL LYS SEQRES 1 E 246 VAL LYS VAL THR GLN SER SER ARG TYR LEU VAL LYS ARG SEQRES 2 E 246 THR GLY GLU LYS VAL PHE LEU GLU CYS VAL GLN ASP MET SEQRES 3 E 246 ASP HIS GLU ASN MET PHE TRP TYR ARG GLN ASP PRO GLY SEQRES 4 E 246 LEU GLY LEU ARG LEU ILE TYR PHE SER TYR ASP VAL LYS SEQRES 5 E 246 MET LYS GLU LYS GLY ASP ILE PRO GLU GLY TYR SER VAL SEQRES 6 E 246 SER ARG GLU LYS LYS GLU ARG PHE SER LEU ILE LEU GLU SEQRES 7 E 246 SER ALA SER THR ASN GLN THR SER MET TYR LEU CYS ALA SEQRES 8 E 246 SER SER SER THR GLY LEU PRO TYR GLY TYR THR PHE GLY SEQRES 9 E 246 SER GLY THR ARG LEU THR VAL VAL GLU ASP LEU ASN LYS SEQRES 10 E 246 VAL PHE PRO PRO GLU VAL ALA VAL PHE GLU PRO SER GLU SEQRES 11 E 246 ALA GLU ILE SER HIS THR GLN LYS ALA THR LEU VAL CYS SEQRES 12 E 246 LEU ALA THR GLY PHE PHE PRO ASP HIS VAL GLU LEU SER SEQRES 13 E 246 TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY VAL SER SEQRES 14 E 246 THR ASP PRO GLN PRO LEU LYS GLU GLN PRO ALA LEU ASN SEQRES 15 E 246 ASP SER ARG TYR SER LEU SER SER ARG LEU ARG VAL SER SEQRES 16 E 246 ALA THR PHE TRP GLN ASN PRO ARG ASN HIS PHE ARG CYS SEQRES 17 E 246 GLN VAL GLN PHE TYR GLY LEU SER GLU ASN ASP GLU TRP SEQRES 18 E 246 THR GLN ASP ARG ALA LYS PRO VAL THR GLN ILE VAL SER SEQRES 19 E 246 ALA GLU ALA TRP GLY ARG ALA ASP CYS GLY PHE THR MODRES 1J8H ASN A 78 ASN GLYCOSYLATION SITE MODRES 1J8H ASN A 118 ASN GLYCOSYLATION SITE MODRES 1J8H ASN B 19 ASN GLYCOSYLATION SITE HET NAG F 1 14 HET NDG F 2 14 HET NAG A 501 14 HET NAG B 521 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE FORMUL 6 NAG 3(C8 H15 N O6) FORMUL 6 NDG C8 H15 N O6 FORMUL 9 HOH *305(H2 O) HELIX 1 1 GLU A 47 ALA A 52 1 6 HELIX 2 2 ALA A 56 SER A 77 1 22 HELIX 3 3 THR B 51 LEU B 53 5 3 HELIX 4 4 GLY B 54 SER B 63 1 10 HELIX 5 5 GLN B 64 ALA B 73 1 10 HELIX 6 6 ALA B 73 TYR B 78 1 6 HELIX 7 7 TYR B 78 GLU B 87 1 10 HELIX 8 8 SER B 88 THR B 90 5 3 HELIX 9 9 ILE D 59 GLY D 61 5 3 HELIX 10 10 HIS D 81 ALA D 85 5 5 HELIX 11 11 ARG D 169 ASP D 172 5 4 HELIX 12 12 SER E 83 THR E 87 5 5 HELIX 13 13 ASP E 119 VAL E 123 5 5 HELIX 14 14 SER E 134 GLN E 142 1 9 HELIX 15 15 ALA E 201 GLN E 205 1 5 SHEET 1 A 8 GLU A 40 TRP A 43 0 SHEET 2 A 8 ASP A 29 ASP A 35 -1 O HIS A 33 N VAL A 42 SHEET 3 A 8 SER A 19 PHE A 26 -1 O PHE A 22 N VAL A 34 SHEET 4 A 8 HIS A 5 ASN A 15 -1 N ILE A 8 O ASP A 25 SHEET 5 A 8 PHE B 7 PHE B 18 -1 N PHE B 7 O ASN A 15 SHEET 6 A 8 ARG B 23 TYR B 32 -1 O ARG B 23 N PHE B 18 SHEET 7 A 8 GLU B 35 ASP B 41 -1 O GLU B 35 N TYR B 32 SHEET 8 A 8 TYR B 47 ALA B 49 -1 N ARG B 48 O ARG B 39 SHEET 1 B 2 SER A 53 PHE A 54 0 SHEET 2 B 2 LYS C 307 TYR C 308 1 N TYR C 308 O SER A 53 SHEET 1 C 4 GLU A 88 THR A 93 0 SHEET 2 C 4 ASN A 103 PHE A 112 -1 N ILE A 106 O LEU A 92 SHEET 3 C 4 PHE A 145 PHE A 153 -1 N PHE A 145 O PHE A 112 SHEET 4 C 4 SER A 133 GLU A 134 -1 O SER A 133 N TYR A 150 SHEET 1 D 4 GLU A 88 THR A 93 0 SHEET 2 D 4 ASN A 103 PHE A 112 -1 N ILE A 106 O LEU A 92 SHEET 3 D 4 PHE A 145 PHE A 153 -1 N PHE A 145 O PHE A 112 SHEET 4 D 4 LEU A 138 PRO A 139 -1 N LEU A 138 O ARG A 146 SHEET 1 E 4 LYS A 126 VAL A 128 0 SHEET 2 E 4 ASN A 118 ARG A 123 -1 O TRP A 121 N VAL A 128 SHEET 3 E 4 VAL A 160 GLU A 166 -1 O ASP A 162 N LEU A 122 SHEET 4 E 4 LEU A 174 GLU A 179 -1 O LEU A 174 N VAL A 165 SHEET 1 F 4 GLU B 98 PRO B 103 0 SHEET 2 F 4 LEU B 114 PHE B 122 -1 N VAL B 116 O TYR B 102 SHEET 3 F 4 PHE B 155 GLU B 162 -1 N PHE B 155 O PHE B 122 SHEET 4 F 4 VAL B 142 SER B 144 -1 O VAL B 143 N MET B 160 SHEET 1 G 4 GLU B 98 PRO B 103 0 SHEET 2 G 4 LEU B 114 PHE B 122 -1 N VAL B 116 O TYR B 102 SHEET 3 G 4 PHE B 155 GLU B 162 -1 N PHE B 155 O PHE B 122 SHEET 4 G 4 ILE B 148 GLN B 149 -1 N ILE B 148 O GLN B 156 SHEET 1 H 4 GLN B 136 GLU B 137 0 SHEET 2 H 4 GLU B 128 ARG B 133 -1 N ARG B 133 O GLN B 136 SHEET 3 H 4 VAL B 170 GLU B 176 -1 O THR B 172 N PHE B 132 SHEET 4 H 4 LEU B 184 ARG B 189 -1 O LEU B 184 N VAL B 175 SHEET 1 I 2 SER D 2 THR D 4 0 SHEET 2 I 2 ASN D 23 SER D 25 -1 O ASN D 23 N THR D 4 SHEET 1 J 4 GLN D 44 TYR D 49 0 SHEET 2 J 4 TYR D 31 GLN D 37 -1 O LEU D 32 N TYR D 49 SHEET 3 J 4 ALA D 86 SER D 93 -1 O GLU D 87 N GLN D 37 SHEET 4 J 4 LEU D 104 PHE D 106 -1 N THR D 105 O VAL D 92 SHEET 1 K 5 GLN D 44 TYR D 49 0 SHEET 2 K 5 TYR D 31 GLN D 37 -1 O LEU D 32 N TYR D 49 SHEET 3 K 5 ALA D 86 SER D 93 -1 O GLU D 87 N GLN D 37 SHEET 4 K 5 THR D 110 ILE D 115 -1 O THR D 110 N TYR D 88 SHEET 5 K 5 HIS D 9 SER D 13 1 O VAL D 10 N THR D 113 SHEET 1 L 4 VAL D 18 LEU D 20 0 SHEET 2 L 4 LEU D 75 LYS D 77 -1 O LEU D 75 N LEU D 20 SHEET 3 L 4 GLU D 63 GLU D 65 -1 O GLU D 63 N THR D 76 SHEET 4 L 4 LEU D 55 LYS D 57 -1 N VAL D 56 O ALA D 64 SHEET 1 M 4 ALA D 124 LEU D 128 0 SHEET 2 M 4 SER D 137 THR D 142 -1 O VAL D 138 N LEU D 128 SHEET 3 M 4 PHE D 173 SER D 182 -1 O ALA D 178 N PHE D 141 SHEET 4 M 4 TYR D 159 ILE D 160 -1 N TYR D 159 O TRP D 181 SHEET 1 N 4 ALA D 124 LEU D 128 0 SHEET 2 N 4 SER D 137 THR D 142 -1 O VAL D 138 N LEU D 128 SHEET 3 N 4 PHE D 173 SER D 182 -1 O ALA D 178 N PHE D 141 SHEET 4 N 4 THR D 164 MET D 168 -1 N THR D 164 O SER D 177 SHEET 1 O 2 VAL E 4 GLN E 6 0 SHEET 2 O 2 CYS E 23 GLN E 25 -1 O VAL E 24 N THR E 5 SHEET 1 P 5 GLU E 56 LYS E 57 0 SHEET 2 P 5 GLY E 42 SER E 49 -1 N PHE E 48 O GLU E 56 SHEET 3 P 5 ASN E 31 ASP E 38 -1 O MET E 32 N SER E 49 SHEET 4 P 5 SER E 88 SER E 95 -1 O MET E 89 N GLN E 37 SHEET 5 P 5 THR E 107 PHE E 108 -1 O THR E 107 N SER E 94 SHEET 1 Q 6 GLU E 56 LYS E 57 0 SHEET 2 Q 6 GLY E 42 SER E 49 -1 N PHE E 48 O GLU E 56 SHEET 3 Q 6 ASN E 31 ASP E 38 -1 O MET E 32 N SER E 49 SHEET 4 Q 6 SER E 88 SER E 95 -1 O MET E 89 N GLN E 37 SHEET 5 Q 6 THR E 112 VAL E 117 -1 O THR E 112 N TYR E 90 SHEET 6 Q 6 TYR E 10 ARG E 14 1 O LEU E 11 N THR E 115 SHEET 1 R 3 VAL E 19 LEU E 21 0 SHEET 2 R 3 SER E 76 LEU E 79 -1 N LEU E 77 O LEU E 21 SHEET 3 R 3 TYR E 65 SER E 68 -1 O SER E 66 N ILE E 78 SHEET 1 S 4 GLU E 127 PHE E 131 0 SHEET 2 S 4 LYS E 143 PHE E 153 -1 O VAL E 147 N PHE E 131 SHEET 3 S 4 TYR E 191 SER E 200 -1 N TYR E 191 O PHE E 153 SHEET 4 S 4 VAL E 173 THR E 175 -1 O SER E 174 N ARG E 196 SHEET 1 T 4 GLU E 127 PHE E 131 0 SHEET 2 T 4 LYS E 143 PHE E 153 -1 O VAL E 147 N PHE E 131 SHEET 3 T 4 TYR E 191 SER E 200 -1 N TYR E 191 O PHE E 153 SHEET 4 T 4 LEU E 180 LYS E 181 -1 N LEU E 180 O SER E 192 SHEET 1 U 4 LYS E 167 VAL E 169 0 SHEET 2 U 4 VAL E 158 VAL E 164 -1 O TRP E 162 N VAL E 169 SHEET 3 U 4 HIS E 210 PHE E 217 -1 O ARG E 212 N TRP E 163 SHEET 4 U 4 GLN E 236 TRP E 243 -1 O GLN E 236 N PHE E 217 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.04 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.05 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.03 SSBOND 4 CYS D 22 CYS D 90 1555 1555 2.03 SSBOND 5 CYS D 139 CYS D 189 1555 1555 2.04 SSBOND 6 CYS E 23 CYS E 92 1555 1555 2.02 SSBOND 7 CYS E 148 CYS E 213 1555 1555 2.02 LINK ND2 ASN A 78 C1 NAG A 501 1555 1555 1.46 LINK ND2 ASN A 118 C1 NAG F 1 1555 1555 1.44 LINK ND2 ASN B 19 C1 NAG B 521 1555 1555 1.45 LINK O4 NAG F 1 C1 NDG F 2 1555 1555 1.39 CISPEP 1 ASN A 15 PRO A 16 0 0.24 CISPEP 2 THR A 113 PRO A 114 0 -0.81 CISPEP 3 TYR B 123 PRO B 124 0 0.70 CISPEP 4 PHE E 154 PRO E 155 0 -0.24 CRYST1 143.753 73.317 123.033 90.00 108.52 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006956 0.000000 0.002330 0.00000 SCALE2 0.000000 0.013639 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008572 0.00000